Vehicles for oligonucleotide delivery to tumours

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 1, 2002, Pages 3-27

  Dass, Crispin R ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ANNAMYCIN; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BETA CYCLODEXTRIN; BREFELDIN A; CHOLESTEROL; CYCLODEXTRIN; CYTOCHALASIN B; DENDRIMER; DRUG CARRIER; DRUG VEHICLE; FLUORESCEIN ISOTHIOCYANATE; GENE PRODUCT; LIPID; LIPOPLEX; LIPOSOME; METHYL BETA CYCLODEXTRIN; MYC PROTEIN; N ETHYLMALEIMIDE; NANOPARTICLE; NUCLEIC ACID; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OLIGODEOXYRIBONUCLEOSIDE METHYLPHOSPHONATE; OLIGONUCLEOTIDE; OLIGOSACCHARIDE; POLYETHYLENEIMINE DERIVATIVE; POLYMER; PORPHYRIN DERIVATIVE; PROTEIN P53; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADVANCED CANCER; ATHEROSCLEROSIS; BLOOD VESSEL PERMEABILITY; CELL TRANSPORT; CHOLESTEROL TRANSPORT; DRUG ACCUMULATION; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG TARGETING; DRUG TUMOR LEVEL; DRUG UPTAKE; GENE DELIVERY SYSTEM; GENE THERAPY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR INTERACTION; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SIDE EFFECT; SOLID TUMOR; STRUCTURE ACTIVITY RELATION; TUMOR VASCULARIZATION;

ANIMALS; CYCLODEXTRINS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; NEOPLASMS; OLIGONUCLEOTIDES; TUMOR CELLS, CULTURED; VEHICLES;

EID: 0036164530     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357021771887     Document Type: Review

References (302)

1. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine
2. Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a corona-virus intergenic consensus sequence
3. Factors affecting the specificity and mechanism of action of antisense oligonucleotide
4. Biodegradable alginate microspheres as a delivery system for naked DNA
5. Safety assessment of selected cyclodextrins-effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis
6. Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the Human Papillomavirus Type 16 E6 gene
7. Cationic lipid-based delivery system for systemic cancer gene therapy
8. Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions
9. Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo
10. Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides
11. Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma
12. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration
13. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes
14. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides
15. Mac-1 (CD11B/CD18) is an oligodeoxynucleotide binding protein
16. Cationic porphyrins: Novel delivery vehicles for antisense oligodeoxynucleotides
17. Determination of cellular internalization of fluoresceinated oligonucleotides
18. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
19. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy
20. Electroporation of synthetic oligodeoxyribonucleotides: A novel technique for ex vivo bone marrow purging
21. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers
22. Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo
23. Chiral separation of antisense oligonucleotides: A feasibility study
24. Localized direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
25. Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo
26. Tumor angiogenesis and interstitial hypertension
27. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine
28. Optimized galenics improve in vitro gene transfer with cationic liposomes up to 1000-fold
29. 2+ and von Willebrand factor release in human endothelial cells
30. Naked DNA delivered intraportally expresses in hepatocytes
31. Hypothesis: A naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process
32. Target site selection for an RNA-cleaving catalytic DNA
33. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: An in vivo study relevant to bone marrow purging
34. Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits
35. Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol
36. Influence of formulation parameters on the characteristics of poly(D, L-lactid-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA
37. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
38. Safety of parenteral hydroxylpropyl β-cyclodextrin
39. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter
40. Liver-directed gene transfer: A linear polyethyleneimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo
41. Rapid nuclear accumulation of injected oligodeoxyribonucleotides
42. Characterization of the nuclear-binding sites of oligodeoxyribonucleotides and their analogues
43. Gene transfer therapy of Gaucher disease
44. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles
45. In vivo delivery to tumors of DNA complexed with linear polyethyleneimine
46. Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene
47. Optimal lipofection reagent varies with the molecular modifications of the DNA
48. An overview of progress in antisense therapeutics
49. Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine
50. Inclusion complex formation of antisense nucleotides with hydroxypropyl-β-cyclodextrin
51. Cyclodextrin news, 13
52. Targeted gene therapy for cancer
53. Lipoplexes and tumours
54. Microsphere-mediated targeted gene therapy of solid tumours
55. Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis
56. Delivery of lipoplexes for genotherapy of solid tumours: Role of vascular endothelial cells
57. In vitro evaluation of ion-exchange microspheres as carriers of plasmid DNA
58. Limitation of lipoplexes for gene therapy of solid tumours
59. Tumour gene-targeting using microspheres: Cell culture and in vivo studies
60. Cationic liposomes and gene therapy for solid tumors
61. Tumour vasculature-summary of recent findings and therapeutic implications
62. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation
63. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumour model
64. Effects of particle size on the efflux of cellular free cholesterol
65. Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences
66. Characterization of complexes of oligunucleotides with polymidoamine starburst dendrimers and effects on intracellular delivery
67. Novel cationic amphiphiles as delivery agent for antisense oligonucleotides
68. Fene transfer by guanidium-cholesterol: Dioleoylphosphatidyl-ethanolamine liposome-DNA complexes in aerosol
69. Polyethylenimine but not cationic lipid improves antisense activity of 3′-capped phosphodiester oligonucleotides
70. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex
71. Plasmid DNA entry into postmitotic nuclei of primary rat myotubes
72. Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo
73. Translocation and RNA-coated gold particles through the nuclear pores of oocytes
74. The effects of variations in the number and sequence of targeting signals on nuclear uptake
75. Large porous particles for pulmonary drug delivery
76. Prophylactic gene therapy for FAP-issues of efficacy and safety in vivo
77. TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo
78. Downregulation of the p75 neurotrophin receptor in tissue culture and in vivo, using β-cyclodextrin-adamantane-oligonucleotide conjugates
79. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides
80. Movement of a karyophilic protein through the nuclear pores of oocytes
81. Size-dependent release of carboxyfluorescein from celtmannoside-modified liposomes in human plasma
82. Hypocholesterolemic action of β-cyclodextrin and its effects on cholesterol metabolism in pigs fed a cholesterol-enriched diet
83. Intracellular disposition and metabolism fluorescently labelled unmodified and modified oligonucleotides microinjected into mammalian cells
84. Antisense comes of age
85. Systemic administration of cationic phosphonolipid/DNA complexes and the relationship between formulation and lung transfection efficiency
86. Fate of β-cyclodextrin in the human intestine
87. Water-soluble, meso-substituted cationic porphyrins - A family of compounds fo cellular delivery of oligonucleotides
88. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes
89. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat
90. Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-β-cyclodextrin
91. Gene-delivery systems using cationic polymers
92. Analysis of oligonucleotide binding, internalization, and intracellular trafficking utilizing a novel radiolabeled crosslinker
93. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis
94. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery
95. New class of polymers for the delivery of macromolecular therapeutics
96. Nucleocytoplasmic transport
97. Polyethyleneimine-based intravenous delivery of transgenes to mouse lung
98. Rapid crossing of the pulmonary endothelial barrier by polyetylenimine/DNA complexes
99. Hybridization properties, nuclease stability, and cellular uptake of the oligonucleotide-aminio-β-cyclodextrins and adamantane conjugates
100. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
101. Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer
102. Size dependent liposome degradation in blood: In vivo/in vitro corelation by kinetic modeling
103. A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumor interstitial fluid pressure
104. Localization and induced expression of fusion genes in the rat lung
105. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter
106. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
107. Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery
108. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model
109. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
110. In vivo gene transfer into the adult mammalian central nervous system by continuous injection of plasmid DNA-cationic liposome complex
111. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation
112. Hydroxypropylcyclodextrins in parenteral use. II. Effects on transport and disposition of lipids in rabbit and humans
113. Characteristics and biodistribution of cationic liposomes and their DNA complexes
114. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells
115. RNA export
116. Whitaker lecture: Delivery of molecules, particles, and cells to solid tumors
117. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism
118. Attenuation of the acute-phase response in thermally injured rats by cholesterol-containing cationic liposomes used as a delivery system for gene therapy
119. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo
120. The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs
121. Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function
122. Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor
123. Effects of polyethyleneimine on endocytosis and lysosome stability
124. Gene delivery from a DNA controlled-release stent in porcine coronary arteries
125. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels
126. Hyperthermia enables tumor-specific nanoparticle delivery: Effect of particle size
127. In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides
128. Uptake of oligodeoxyribonucleotides by lymphoid cells is heterogeneous and inducible
129. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle
130. Gene transfection using biodegradable nanospheres: Results in tissue culture and a rat osteotomy model
131. Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes
132. 2+ channel structure and function with antisense oligonucleotides
133. Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells
134. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV E7 mRNA in CaSki cells
135. Bcl-xL in prostate cancer cells: Effects of overexpression and down-regulation on chemosensitivity
136. Percutaneous arterial gene transfer in a rabbit model
137. Uptake and intracellular fate of polyethylenemine in vivo
138. A protein that shuttles between the nucleus and the cytoplasm is an important mediator of RNA export
139. In vivo characterization of sustained-release formulations of human growth hormone
140. Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression
141. Expression of exogenous DNA in rat liver cells after liposome-mediated transfection in vivo
142. Optimisation of polyethyleneimine-based gene delivery to mouse brain
143. Intracellular distribution of microinjected antisense oligonucleotides
144. DNA-polycation nanospheres as non-viral gene delivery vehicles
145. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice
146. Oligonucleotide delivery: A cellular prospective
147. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog
148. The significance of heterogeneous tumor cell clumps in the metastatic process
149. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes
150. Fate of cationic liposomes and their complex with oligonucleotide in vivo
151. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes
152. Cationic liposome-mediated intravenous gene delivery
153. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
154. Systemic gene delivery expands the repertoire of effective antiangiogenic agents
155. Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium
156. Characterization of oligonucleotide transport into living cells
157. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo
158. Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle
159. Synthetic DNA delivery systems
160. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration
161. 125I-labelled polyamidoamine dendrimers in vivo
162. Dexamethasone enhancement of gene expression after direct hepatic DNA injection
163. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus
164. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polymidoamine dendrimer
165. Biologically erodable microspheres as potential oral drug delivery systems
166. Phosphorothioate analogs of oligodeoxynucleotides: Inhibitors of replication and cytopathic effects of human immunodeficiency virus
167. Gene transfer to the retina by liposome eye drops
168. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy
169. Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice
170. Studies on the mechanism of retention of porphyrins and metalloporphyrins by cancer cells
171. Mechanisms of nuclear protein import
172. Endocytosis and molecular sorting
173. Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres
174. Multiple systemic expression of human interferon-β in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex
175. Nasal application of the cationic liposome DC-Chol: DOPE does not alter ion transport, lung function or bacterial growth
176. Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain
177. Cationic lipid-mediated transfection of cells in culture requires mitotic activity
178. Catheter-mediated pulmonary vascular gene transfer and expression
179. Novel polymeric condensing carriers for gene delivery
180. Targeting solid tumours: Challenges, disappointments, and opportunities
181. Site-specific gene expression in vivo by direct gene transfer into the arterial wall
182. Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization
183. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia
184. Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo
185. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo
186. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biological activity, and lack of toxicity in humans
187. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma
188. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes
189. Is control of distribution of liposomes between tumors and bone marrow possible?
190. RNA transport
191. Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: Cationic liposomal gene therapy of carcinomatosa
192. Cationic lipid is not required for selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes
193. High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation
194. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer
195. Characteristics of oligonucleotide uptake in human keratinocyte cultures
196. Evaluation of cationic liposome suitable for gene transfer into pregnant animals
197. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells
198. 33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: Use of a novel radionuclide approachs
199. Periadventitial lacZ gene transfer to pig carotid arteries using a biodegradable collagen collar or a wrap of collagen sheet with adenoviruses and plasmid-liposome complexes
200. Cancer gene therapy using plasmid DNA: Safety evaluation in rodents and non-human primates
201. Gene therapy of HNSCC with liposomal mediated h-IL-2 plasmids-phase I-study
202. In vivo gene delivery. Efficient transfection of T lymphocytes in adult mice
203. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide
204. Intracellular localization of oligonucleotides: Influence of fixative protocols
205. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm
206. Polyethyleneimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells
207. Nuclear import of polypeptides, polynucleotides and supramolecular complexes
208. Encapsulation of proteins for improved delivery
209. Enhanced antitumor effects with microencapsulated c-myc antisense oligonucleotide
210. Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium
211. Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms
212. Electroporation-mediated delivery of 3′-protected phosphodiester oligodeoxynucleotides to the skin
213. Hypolipidemic effects of β-cyclodextrin in the hamster and in the genetically hypercholesterolemic Rico rat
214. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides
215. Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes
216. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
217. In vivo gene delivery to the lung using polyethyleneimine and fractured polyamidoamine dendrimers
218. Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cell proliferation
219. Percutaneous in vivo gene transfer to the peripheral lungs using plasmid-liposome complexes
220. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
221. Liposome mediated gene transfer into the rat oesophagus
222. Direct gene transfer into the rat pancreas using DNA-liposomes
223. Hypethermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues
224. Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I
225. Modified deoxyoligonucleotides stable to exonuclease degradation in serum
226. DNA delivery from polymer matrices for tissue engineering
227. Encapsulation and release of rhodium (II) citrate and its association complex with hydroxypropyl-β-cyclodextrin from biodegradable polymer microspheres
228. Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer
229. Factors influencing the drug sensitization of human tumor cells for in situ lipofection
230. Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration
231. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmids DNA
232. Nuclear delivery of antisense oligodeoxyribonucleotides through reversible permeabilization of human leukemia cells with streptolysin-O
233. Dynamics of the internalization of phosphodiester oligodexoynucleotides in HL60 cells
234. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo
235. +-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema
236. Gene transfer in vivo with DNA-liposome complexes: Safety and acute toxicity in mice
237. The nuclear pore complex: From molecular architecture to functional dynamics
238. In vivo gene transfer methods into bladder without viral vectors
239. Effect of the platelet-activating factor antagonist BN50739 and its diluents on mitochondrial respiration and membrane lipids during and following cerebral ischemia
240. Suppression of smooth muscle cell (SMC) proliferation by a c-myc RNA-cleaving deoxyribozyme
241. Catalytic nucleic acids: From lab to applications
242. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: Growth inhibition of tumors and lack of localization in normal tissues
243. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation
244. Delivery of oligoribonucleotides to human hepatoma cells using cationic lipid particles conjugated to ferric protoporphyrin IX (heme)
245. Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter
246. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes
247. In vitro gene delivery by degraded polyamidoamine dendrimers
248. A convenient synthesis of 5′-amino-5′-deoxythymidine and preparation of peptide-DNA hybrids
249. Systemic gene therapy: Biodistribution and long-term expression of a transgene in mice
250. Formulation of poly(D, L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery
251. Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology and flexibility from atoms to macroscopic matter
252. Direct in vivo gene introduction into rat kidney
253. Carcinogenicity study of beta-cyclodextrin in F344 rats
254. Controlled gene delivery by DNA-gelatin nanospheres
255. Lung-specific direct in vivo gene transfer with recombinant plasmid DNA
256. Tumor localizer: Porphyrins and related compounds (unusual metalloporphyrins XXIII)
257. Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo
258. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes
259. Pharmacokinetic and tumor-photo-sensitizing properties of the cationic porphyrin meso-tetra (4N-methylpyridyl) porphine
260. Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides
261. Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells
262. Cholesterol efflux from macrophages and other cells
263. Antisense gene inhibition by oligonucleotides containing C-5 propene pyrimidines
264. Combined platinum and c-myc antisense therapy in a rat solid tumour model
265. A method for intratumoral continuous infusion of antisense oligodeoxynucleotides
266. Cationic liposome mediated transgene expression in the guinea pig cochlea
267. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung
268. Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice
269. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle
270. Cationic lipid binding to DNA: Characterization of complex formation
271. β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: A cautionary tale
272. Fusion of cationic liposomes with mammalian cells occurs after endocytosis
273. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue
274. Antisense c-myc oligodeoxyribonucleotide cellular uptake
275. Transferin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts
276. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity
277. In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes
278. Mechanisms of oligonucleotide uptake by cells: Involvement of specific receptors?
279. Intracellular hyperthermia for cancer using magnetite cationic liposomes: An in vivo study
280. Effects of sequence of thioated oligonucleotides on culture human mammary epithelial cells
281. Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes
282. PAMAM dendrimers as delivery agents for antisense oligonucleotides
283. Expression of the cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer
284. Transvacular drug delivery in solid tumors
285. Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes
286. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids
287. Mechanism of oligonucleotide release from cationic liposomes
288. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complex and on their interactions with cells
289. Expression of naked plasmid DNA infected into the afferent and efferent vessels of rodent and dog livers
290. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA
291. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides
292. Use of cyclodextrin and its derivatives as carriers for oligonucleotide delivery
293. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation
294. Effect of different chemically modified oligodeoxynucleotides on immune stimulation
295. Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice
296. A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy
297. Systemic gene expression after intravenous DNA delivery into adult mice
298. Effect of vesicle size and lipid composition on the in vivo tumor selectively and toxicity of the non-cross-resistant antracycline annamycin incorporated in liposomes
299. Effective treatment of early endobronchial cancer with regional administration of liposomes-p53 complexes
300. Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse
301. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer